Among adults with chronic rhinosinusitis with nasal polyps who endured endoscopic sinus surgery, those with severe vs. mild ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Labelling warns that certain nasal conditions, such as nasal polyps or a history of nasal surgery, may affect the absorption of the new drug. ARS said it will launch the product onto the market ...

Allegra and Claritin are both allergy medications, helping relieve symptoms like sneezing, a runny nose, or itchy eyes. But the active ingredients in each are different. Allegra contains ...